Format

Send to:

Choose Destination
See comment in PubMed Commons below
Expert Opin Ther Targets. 2010 Jun;14(6):633-45. doi: 10.1517/14728221003752743.

The apelinergic system: a promising therapeutic target.

Author information

  • 1University of Porto, Department of Physiology, Cardiovascular R&D Unit, Faculty of Medicine, Alameda Professor Hernâni Monteiro, 4200-319, Porto, Portugal.

Abstract

IMPORTANCE OF THE FIELD:

Apelin is a bioactive peptide known as the ligand of the G-protein-coupled receptor APJ. In recent years, there has been a growing body of evidence regarding the importance of apelin and APJ in the pathophysiology of cardiovascular, metabolic and gastrointestinal diseases, brain signalling, HIV infection and tumor angiogenesis. Therefore, the apelinergic system is involved in the pathogenesis of several diseases that represent a major burden to our society.

AREAS COVERED IN THIS REVIEW:

The goal of this paper is to give an up-to-date review of existing information on apelin/APJ since the discovery of apelin in 1998, with particular focus on their involvement in the regulation of human body systems and potential therapeutic applications.

WHAT THE READER WILL GAIN:

An overview of the most important physiological functions of the apelinergic system and the diseases that may benefit in the future from its modulation as a therapeutic target.

TAKE HOME MESSAGE:

Today, the established biological effects of apelin involve major cardiovascular actions, neoangiogenesis, immunologic modulation and insulinemia control as well as body fluid and glucose homeostasis. However, the physiological and pathophysiological role of endogenous apelin is still unsettled and a better and profound knowledge of this system in humans is necessary for the development of novel apelinergic-based therapeutic targets.

PMID:
20350050
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Informa Healthcare
    Loading ...
    Write to the Help Desk